<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31426366</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>16</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Neuromuscular Junction as an Entity of Nerve-Muscle Communication.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">906</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells8080906</ELocationID><Abstract><AbstractText>One of the crucial systems severely affected in several neuromuscular diseases is the loss of effective connection between muscle and nerve, leading to a pathological non-communication between the two tissues. The neuromuscular junction (NMJ) represents the critical region at the level of which muscle and nerve communicate. Defects in signal transmission between terminal nerve endings and muscle membrane is a common feature of several physio-pathologic conditions including aging and Amyotrophic Lateral Sclerosis (ALS). Nevertheless, controversy exists on whether pathological events beginning at the NMJ precede or follow loss of motor units. In this review, the role of NMJ in the physio-pathologic interplay between muscle and nerve is discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lepore</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via A. Scarpa, 14, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casola</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via A. Scarpa, 14, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobrowolny</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8693-0724</Identifier><AffiliationInfo><Affiliation>Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via A. Scarpa, 14, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musar&#xf2;</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2944-9739</Identifier><AffiliationInfo><Affiliation>Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via A. Scarpa, 14, 00161 Rome, Italy. antonio.musaro@uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.13</RegistryNumber><NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011493" MajorTopicYN="N">Protein Kinase C</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012583" MajorTopicYN="Y">Schwann Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">NMJ</Keyword><Keyword MajorTopicYN="N">PKC</Keyword><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">muscle-nerve interaction</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31426366</ArticleId><ArticleId IdType="pmc">PMC6721719</ArticleId><ArticleId IdType="doi">10.3390/cells8080906</ArticleId><ArticleId IdType="pii">cells8080906</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rudolf R., Khan M.M., Witzemann V. Motor Endplate&#x2014;Anatomical, Functional, and Molecular Concepts in the Historical Perspective. Cells. 2019;8:387. doi: 10.3390/cells8050387.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8050387</ArticleId><ArticleId IdType="pmc">PMC6562597</ArticleId><ArticleId IdType="pubmed">31035624</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe8;ge R.M., Goudou D., Giaume C., Nicolet M., Rieger F. Is intercellular communication via gap junctions required for myoblast fusion? Cell Adhes. Commun. 1994;2:329&#x2013;343. doi: 10.3109/15419069409014208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15419069409014208</ArticleId><ArticleId IdType="pubmed">7820536</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S., Reggiani C. Molecular diversity of myofibrillar proteins: Gene regulation and functional significance. Physiol. Rev. 1996;76:371&#x2013;423. doi: 10.1152/physrev.1996.76.2.371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1996.76.2.371</ArticleId><ArticleId IdType="pubmed">8618961</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes S.M. Muscle development: Electrical control of gene expression. Curr. Biol. 1998;8:R892&#x2013;R894. doi: 10.1016/S0960-9822(07)00554-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(07)00554-4</ArticleId><ArticleId IdType="pubmed">9843678</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson E.N., Williams R.S. Calcineurin signaling and muscle remodeling. Cell. 2000;101:689&#x2013;692. doi: 10.1016/S0092-8674(00)80880-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80880-6</ArticleId><ArticleId IdType="pubmed">10892739</ArticleId></ArticleIdList></Reference><Reference><Citation>Buller A.J., Eccles J.C., Eccles R.M. Differentiation of fast and slow muscles in the cat hind limb. J. Physiol. 1960;150:399&#x2013;416. doi: 10.1113/jphysiol.1960.sp006394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1960.sp006394</ArticleId><ArticleId IdType="pmc">PMC1363171</ArticleId><ArticleId IdType="pubmed">13805873</ArticleId></ArticleIdList></Reference><Reference><Citation>Pette D., Vrbov&#xe1; G. Neural control of phenotypic expression in mammalian muscle fibers. Muscle Nerve. 1985;8:676&#x2013;689. doi: 10.1002/mus.880080810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880080810</ArticleId><ArticleId IdType="pubmed">3903491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kablar B., Rudnicki M.A. Development in the Absence of Skeletal Muscle Results in the Sequential Ablation of Motor Neurons from the Spinal Cord to the Brain. Dev. Biol. 1999;208:93&#x2013;109. doi: 10.1006/dbio.1998.9184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/dbio.1998.9184</ArticleId><ArticleId IdType="pubmed">10075844</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Wei-LaPierre L., Klose A., Dirksen R.T., Chakkalakal J.V. Inducible depletion of adult skeletal muscle stem cells impairs the regeneration of neuromuscular junctions. eLife. 2015;4:e09221. doi: 10.7554/eLife.09221.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.09221</ArticleId><ArticleId IdType="pmc">PMC4579298</ArticleId><ArticleId IdType="pubmed">26312504</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z., Ko C.-P. Schwann Cells Promote Synaptogenesis at the Neuromuscular Junction via Transforming Growth Factor- 1. J. Neurosci. 2008;28:9599&#x2013;9609. doi: 10.1523/JNEUROSCI.2589-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2589-08.2008</ArticleId><ArticleId IdType="pmc">PMC3844879</ArticleId><ArticleId IdType="pubmed">18815246</ArticleId></ArticleIdList></Reference><Reference><Citation>Koirala S., Reddy L.V., Ko C.-P. Roles of glial cells in the formation, function, and maintenance of the neuromuscular junction. J. Neurosci. 2003;32:987&#x2013;1002. doi: 10.1023/B:NEUR.0000020637.71452.3c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:NEUR.0000020637.71452.3c</ArticleId><ArticleId IdType="pubmed">15034281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W., Sanchez H.B., Deerinck T., Morris J.K., Ellisman M., Lee K.-F. Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. Proc. Natl. Acad. Sci. USA. 2000 doi: 10.1073/pnas.97.3.1299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.3.1299</ArticleId><ArticleId IdType="pmc">PMC15603</ArticleId><ArticleId IdType="pubmed">10655525</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousse I., St.-Amour A., Darabid H., Robitaille R. Synapse-glia interactions are governed by synaptic and intrinsic glial properties. Neuroscience. 2010 doi: 10.1016/j.neuroscience.2010.02.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.02.036</ArticleId><ArticleId IdType="pubmed">20188148</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z., Ko C.-P. The role of glial cells in the formation and maintenance of the neuromuscular junction. Ann. N. Y. Acad. Sci. 2008;1132:19&#x2013;28. doi: 10.1196/annals.1405.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1405.016</ArticleId><ArticleId IdType="pubmed">18567850</ArticleId></ArticleIdList></Reference><Reference><Citation>Court F.A., Gillingwater T.H., Melrose S., Sherman D.L., Greenshields K.N., Morton A.J., Harris J.B., Willison H.J., Ribchester R.R. Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. J. Cell Sci. 2008 doi: 10.1242/jcs.031047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.031047</ArticleId><ArticleId IdType="pubmed">19001504</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis J., Fine S.M., David C., Savarirayan S., Sanes J.R. Integration site-dependent expression of a transgene reveals specialized features of cells associated with neuromuscular junctions. J. Cell Biol. 1991 doi: 10.1083/jcb.113.6.1385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.113.6.1385</ArticleId><ArticleId IdType="pmc">PMC2289028</ArticleId><ArticleId IdType="pubmed">1904446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura Y., Lin W. Neuron-glia interactions: The roles of Schwann cells in neuromuscular synapse formation and function. Biosci. Rep. 2011;31:295&#x2013;302. doi: 10.1042/BSR20100107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20100107</ArticleId><ArticleId IdType="pmc">PMC4573580</ArticleId><ArticleId IdType="pubmed">21517783</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Ot&#xed;n C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell. 2013 doi: 10.1016/j.cell.2013.05.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.05.039</ArticleId><ArticleId IdType="pmc">PMC3836174</ArticleId><ArticleId IdType="pubmed">23746838</ArticleId></ArticleIdList></Reference><Reference><Citation>Musar&#xf2; A. Understanding ALS: New therapeutic approaches. FEBS J. 2013;280:4315&#x2013;4322. doi: 10.1111/febs.12087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12087</ArticleId><ArticleId IdType="pubmed">23217177</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K.H.J. Mechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral Sclerosis. Aging Dis. 2015;6:380&#x2013;389. doi: 10.14336/AD.2015.0506.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2015.0506</ArticleId><ArticleId IdType="pmc">PMC4567220</ArticleId><ArticleId IdType="pubmed">26425392</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a M.L., Fern&#xe1;ndez A., Solas M.T. Mitochondria, motor neurons and aging. J. Neurol. Sci. 2013;330:18&#x2013;26. doi: 10.1016/j.jns.2013.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2013.03.019</ArticleId><ArticleId IdType="pubmed">23628465</ArticleId></ArticleIdList></Reference><Reference><Citation>Scicchitano B.M., Pelosi L., Sica G., Musar&#xf2; A. The physiopathologic role of oxidative stress in skeletal muscle. Mech. Ageing Dev. 2018;170:37&#x2013;44. doi: 10.1016/j.mad.2017.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2017.08.009</ArticleId><ArticleId IdType="pubmed">28851603</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Martini M., Scicchitano B.M., Romanello V., Boncompagni S., Nicoletti C., Pietrangelo L., De Panfilis S., Catizone A., Bouch&#xe8; M., et al. Muscle Expression of SOD1G93A Triggers the Dismantlement of Neuromuscular Junction via PKC-Theta. Antioxid. Redox Signal. 2018;28:1105&#x2013;1119. doi: 10.1089/ars.2017.7054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7054</ArticleId><ArticleId IdType="pubmed">28931313</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Cortez C., Gan W.B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014 doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J., Putman C.T., Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2007;28:154&#x2013;164. doi: 10.1016/j.nbd.2007.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J., Putman C.T., Tyreman N., Gordon T. Preferential motor unit loss in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Physiol. 2008;586:3337&#x2013;3351. doi: 10.1113/jphysiol.2007.149286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.149286</ArticleId><ArticleId IdType="pmc">PMC2538809</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId></ArticleIdList></Reference><Reference><Citation>De Winter F., Vo T., Stam F.J., Wisman L.A.B., B&#xe4;r P.R., Niclou S.P., van Muiswinkel F.L., Verhaagen J. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol. Cell. Neurosci. 2006;32:102&#x2013;117. doi: 10.1016/j.mcn.2006.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2006.03.002</ArticleId><ArticleId IdType="pubmed">16677822</ArticleId></ArticleIdList></Reference><Reference><Citation>Chance P.F., Rabin B.A., Ryan S.G., Ding Y., Scavina M., Crain B., Griffin J.W., Cornblath D.R. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am. J. Hum. Genet. 1998;62:633&#x2013;640. doi: 10.1086/301769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/301769</ArticleId><ArticleId IdType="pmc">PMC1376963</ArticleId><ArticleId IdType="pubmed">9497266</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Hentati A., Deng H.X., Dabbagh O., Sasaki T., Hirano M., Hung W.Y., Ouahchi K., Yan J., Azim A.C., et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 2001;29:160&#x2013;165. doi: 10.1038/ng1001-160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1001-160</ArticleId><ArticleId IdType="pubmed">11586297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., Miyamoto N., Showguchi-Miyata J., Okada Y., Singaraja R., et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 2001 doi: 10.1038/ng1001-166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1001-166</ArticleId><ArticleId IdType="pubmed">11586298</ArticleId></ArticleIdList></Reference><Reference><Citation>Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L.F., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., et al. Mutant dynactin in motor neuron disease. Nat. Genet. 2003;33:455&#x2013;456. doi: 10.1038/ng1123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1123</ArticleId><ArticleId IdType="pubmed">12627231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Mitne-Neto M., Silva H.C.A., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R.M., Gillingwater T., Webb J., et al. A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis. Am. J. Hum. Genet. 2004 doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009 doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA. 2009 doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.H., Fallini C., Ticozzi N., Keagle P.J., Sapp P.C., Piotrowska K., Lowe P., Koppers M., McKenna-Yasek D., Baron D.M., et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012 doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A.C., Bendotti C., Blaugrund E., Chio A., Greensmith L., Loeffler J.P., Mead R., Niessen H.G., Petri S., Pradat P.F., et al. Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotroph. Lateral Scler. 2010 doi: 10.3109/17482960903545334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903545334</ArticleId><ArticleId IdType="pubmed">20184514</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giorgio F., Maduro C., Fisher E.M.C., Acevedo-Arozena A. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis. Dis. Model. Mech. 2019;12 doi: 10.1242/dmm.037424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.037424</ArticleId><ArticleId IdType="pmc">PMC6361152</ArticleId><ArticleId IdType="pubmed">30626575</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino M.M., Schneider C., Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 2002;22:4825&#x2013;4832. doi: 10.1523/JNEUROSCI.22-12-04825.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-12-04825.2002</ArticleId><ArticleId IdType="pmc">PMC6757755</ArticleId><ArticleId IdType="pubmed">12077179</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boill&#xe9;e S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003 doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Bonconpagni S., Belia S., Wannenes F., Nicoletti C., Del Prete Z., et al. Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M., Martin L.J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010;19:2284&#x2013;2302. doi: 10.1093/hmg/ddq106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq106</ArticleId><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo G., Yi J., Ma C., Xiao Y., Yi F., Yu T., Zhou J. Defective Mitochondrial Dynamics Is an Early Event in Skeletal Muscle of an Amyotrophic Lateral Sclerosis Mouse Model. PLoS ONE. 2013;8:e82112. doi: 10.1371/journal.pone.0082112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082112</ArticleId><ArticleId IdType="pmc">PMC3855744</ArticleId><ArticleId IdType="pubmed">24324755</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolf R., Deschenes M.R., Sandri M. Neuromuscular junction degeneration in muscle wasting. Curr. Opin. Clin. Nutr. Metab. Care. 2016;19:177&#x2013;181. doi: 10.1097/MCO.0000000000000267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000267</ArticleId><ArticleId IdType="pmc">PMC4946244</ArticleId><ArticleId IdType="pubmed">26870889</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004 doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer A.M., Sanes J.R., Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 2005;490:209&#x2013;219. doi: 10.1002/cne.20620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20620</ArticleId><ArticleId IdType="pubmed">16082680</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 2001 doi: 10.1038/88842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/88842</ArticleId><ArticleId IdType="pubmed">11381259</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz G., Jordan H., Krekelberg B., Richert M., Reyes J., Foundation T.S., Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004;429:413&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">15164063</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Pena Y., Valenzuela I., Pires-Oliveira M., Akaaboune M. PKC and PKA regulate AChR dynamics at the neuromuscular junction of living mice. PLoS ONE. 2013 doi: 10.1371/journal.pone.0081311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081311</ArticleId><ArticleId IdType="pmc">PMC3829966</ArticleId><ArticleId IdType="pubmed">24260568</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.-X., Jia M., Yang L.-X., Jiang H., Lanuza M.A., Gonzalez C.M., Nelson P.G. The role of the theta isoform of protein kinase C (PKC) in activity-dependent synapse elimination: Evidence from the PKC theta knock-out mouse in vivo and in vitro. J. Neurosci. 2004;24:3762&#x2013;3769. doi: 10.1523/JNEUROSCI.3930-03.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3930-03.2004</ArticleId><ArticleId IdType="pmc">PMC6729339</ArticleId><ArticleId IdType="pubmed">15084656</ArticleId></ArticleIdList></Reference><Reference><Citation>Camerino G.M., Bouch&#xe8; M., De Bellis M., Cannone M., Liantonio A., Musaraj K., Romano R., Smeriglio P., Madaro L., Giustino A., et al. Protein kinase C theta (PKC&#x3b8;) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: A biophysical and gene expression study in mouse models lacking the PKC&#x3b8;. Pfl&#xfc;gers Arch. Eur. J. Physiol. 2014;466:2215&#x2013;2228. doi: 10.1007/s00424-014-1495-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-014-1495-1</ArticleId><ArticleId IdType="pubmed">24643479</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra C., Federici M., Buongiorno A., Senni M.I., Morelli S., Segratella E., Pascuccio M., Tiveron C., Mattei E., Tatangelo L., et al. Transgenic mice with dominant negative PKC-theta in skeletal muscle: A new model of insulin resistance and obesity. J. Cell. Physiol. 2003;196:89&#x2013;97. doi: 10.1002/jcp.10278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.10278</ArticleId><ArticleId IdType="pubmed">12767044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis E.J., Neville H.E. Management of ALS: Nutritional care. Neurology. 1996;47:S118&#x2013;S120. doi: 10.1212/WNL.47.4_Suppl_2.118S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.47.4_Suppl_2.118S</ArticleId><ArticleId IdType="pubmed">8858066</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J.-C., Torny F., Lacoste M., Preux P.-M., Couratier P. Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters. Neurodegener. Dis. 2005;2:202&#x2013;207. doi: 10.1159/000089626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089626</ArticleId><ArticleId IdType="pubmed">16909026</ArticleId></ArticleIdList></Reference><Reference><Citation>Funalot B., Desport J.-C., Sturtz F., Camu W., Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2009;10:113&#x2013;117. doi: 10.1080/17482960802295192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802295192</ArticleId><ArticleId IdType="pubmed">18792852</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C., Desport J.-C., Clavelou P., Guy N., Derumeaux-Burel H., Ferrier A., Couratier P. Hypermetabolism in ALS patients: An early and persistent phenomenon. J. Neurol. 2009;256:1236&#x2013;1242. doi: 10.1007/s00415-009-5100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Corcia P., Fergani A., Gonzalez De Aguilar J.-L., Bonnefont-Rousselot D., Bittar R., Seilhean D., Hauw J.-J., Lacomblez L., Loeffler J.-P., et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman M.H.B., Seelen M., van Doormaal P.T.C., de Jong S.W., de Vries J.H.M., van der Kooi A.J., de Visser M., Schelhaas H.J., van den Berg L.H., Veldink J.H. Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis. JAMA Neurol. 2015;72:1155&#x2013;1162. doi: 10.1001/jamaneurol.2015.1584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.1584</ArticleId><ArticleId IdType="pubmed">26280944</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Gonzalez de Aguilar J.-L., Oudart H., de Tapia M., Barbeito L., Loeffler J.-P. Mitochondria in Amyotrophic Lateral Sclerosis: A Trigger and a Target. Neurodegener. Dis. 2004;1:245&#x2013;254. doi: 10.1159/000085063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000085063</ArticleId><ArticleId IdType="pubmed">16908975</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L., Schlagowski A., Ngo S.T., Vernay A., Dirrig-Grosch S., Henriques A., Boutillier A.-L., Zoll J., Echaniz-Laguna A., Loeffler J.-P., et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Lepore E., Martini M., Barberi L., Nunn A., Scicchitano B.M., Musar&#xf2; A. Metabolic Changes Associated with Muscle Expression of SOD1G93A. Front. Physiol. 2018;9:831. doi: 10.3389/fphys.2018.00831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00831</ArticleId><ArticleId IdType="pmc">PMC6048270</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M.T., Cozzolino M. SOD1 and mitochondria in ALS: A dangerous liaison. J. Bioenerg. Biomembr. 2011;43:593&#x2013;599. doi: 10.1007/s10863-011-9394-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10863-011-9394-z</ArticleId><ArticleId IdType="pubmed">22081209</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi P., Wei Y., Zhang J., Gal J., Zhu H. Mitochondrial Dysfunction is a Converging Point of Multiple Pathological Pathways in Amyotrophic Lateral Sclerosis. J. Alzheimer&#x2019;s Dis. 2010;20:S311&#x2013;S324. doi: 10.3233/JAD-2010-100366.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-100366</ArticleId><ArticleId IdType="pubmed">20463400</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett E.F., Barrett J.N., David G. Dysfunctional mitochondrial Ca2+ handling in mutant SOD1 mouse models of fALS: Integration of findings from motor neuron somata and motor terminals. Front. Cell. Neurosci. 2014;8:184. doi: 10.3389/fncel.2014.00184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00184</ArticleId><ArticleId IdType="pmc">PMC4085874</ArticleId><ArticleId IdType="pubmed">25071445</ArticleId></ArticleIdList></Reference><Reference><Citation>Villegas R., Martinez N.W., Lillo J., Pihan P., Hernandez D., Twiss J.L., Court F.A. Calcium Release from Intra-Axonal Endoplasmic Reticulum Leads to Axon Degeneration through Mitochondrial Dysfunction. J. Neurosci. 2014;34:7179&#x2013;7189. doi: 10.1523/JNEUROSCI.4784-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4784-13.2014</ArticleId><ArticleId IdType="pmc">PMC4028495</ArticleId><ArticleId IdType="pubmed">24849352</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot J.D., Barrett J.N., Nonner D., Zhang Z., Wicomb K., Barrett E.F. Preservation of neuromuscular function in symptomatic SOD1-G93A mice by peripheral infusion of methylene blue. Exp. Neurol. 2016;285:96&#x2013;107. doi: 10.1016/j.expneurol.2016.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.08.013</ArticleId><ArticleId IdType="pubmed">27567739</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Gonzalez de Aguilar J.-L., Echaniz-Laguna A., Eschbach J., Rene F., Oudart H., Halter B., Huze C., Schaeffer L., Bouillaud F., et al. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS ONE. 2009;4:e5390. doi: 10.1371/journal.pone.0005390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005390</ArticleId><ArticleId IdType="pmc">PMC2671839</ArticleId><ArticleId IdType="pubmed">19404401</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohajeri M.H., Figlewicz D.A., Bohn M.C. Intramuscular Grafts of Myoblasts Genetically Modified to Secrete Glial Cell Line-Derived Neurotrophic Factor Prevent Motoneuron Loss and Disease Progression in a Mouse Model of Familial Amyotrophic Lateral Sclerosis. Hum. Gene Ther. 1999;10:1853&#x2013;1866. doi: 10.1089/10430349950017536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/10430349950017536</ArticleId><ArticleId IdType="pubmed">10446925</ArticleId></ArticleIdList></Reference><Reference><Citation>Acsadi G., Anguelov R.A., Yang H., Toth G., Thomas R., Jani A., Wang Y., Ianakova E., Mohammad S., Lewis R.A., et al. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy. Hum. Gene Ther. 2002;13:1047&#x2013;1059. doi: 10.1089/104303402753812458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/104303402753812458</ArticleId><ArticleId IdType="pubmed">12067438</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaspar B.K. Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model. Science. 2003;301:839&#x2013;842. doi: 10.1126/science.1086137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086137</ArticleId><ArticleId IdType="pubmed">12907804</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovsky E.D., Gelir E., Gelir S., Lui H., Kattash M., Demayo F.J., Shenaq S.M., Schwartz R.J. Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. FASEB J. 2003;17:53&#x2013;55. doi: 10.1096/fj.02-0183fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.02-0183fje</ArticleId><ArticleId IdType="pubmed">12424223</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., Molinaro M., Rosenthal N., Musar&#xf2; A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell Biol. 2005;168:193&#x2013;199. doi: 10.1083/jcb.200407021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200407021</ArticleId><ArticleId IdType="pmc">PMC2171577</ArticleId><ArticleId IdType="pubmed">15657392</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdinler P.H., Macklis J.D. IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat. Neurosci. 2006;9:1371&#x2013;1381. doi: 10.1038/nn1789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1789</ArticleId><ArticleId IdType="pubmed">17057708</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Li Y., Yu S., Du W., Zhang L., Dai Y., Liu Y., Li N. Expression of insulin-like growth factors systems in cloned cattle dead within hours after birth. Mol. Reprod. Dev. 2007;74:397&#x2013;402. doi: 10.1002/mrd.20534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrd.20534</ArticleId><ArticleId IdType="pubmed">17094113</ArticleId></ArticleIdList></Reference><Reference><Citation>Musar&#xf2; A., McCullagh K., Paul A., Houghton L., Dobrowolny G., Molinaro M., Barton E.R., L Sweeney H., Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 2001;27:195&#x2013;200. doi: 10.1038/84839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/84839</ArticleId><ArticleId IdType="pubmed">11175789</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakowski S.A., Schuyler A.D., Feldman E.L. Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2009;10:63&#x2013;73. doi: 10.1080/17482960802160370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802160370</ArticleId><ArticleId IdType="pmc">PMC3211070</ArticleId><ArticleId IdType="pubmed">18608100</ArticleId></ArticleIdList></Reference><Reference><Citation>Musar&#xf2; A., Dobrowolny G., Cambieri C., Onesti E., Ceccanti M., Frasca V., Pisano A., Cerbelli B., Lepore E., Ruffolo G., et al. Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: Results of a randomized, double-blind, controlled study. Sci. Rep. 2019;9:2837. doi: 10.1038/s41598-019-39313-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39313-z</ArticleId><ArticleId IdType="pmc">PMC6391419</ArticleId><ArticleId IdType="pubmed">30808899</ArticleId></ArticleIdList></Reference><Reference><Citation>Witzemann V., Brenner H.R., Sakmann B. Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses. J. Cell Biol. 1991;114:125&#x2013;141. doi: 10.1083/jcb.114.1.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.114.1.125</ArticleId><ArticleId IdType="pmc">PMC2289058</ArticleId><ArticleId IdType="pubmed">1646821</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta-Ghosh A., Dominguez S.L., Xie L., Barck K.H., Jiang Z., Earr T., Imperio J., Phu L., Budayeva H.G., Kirkpatrick D.S., et al. Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1G93A mouse model of ALS. Neurobiol. Dis. 2019;124:340&#x2013;352. doi: 10.1016/j.nbd.2018.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.12.002</ArticleId><ArticleId IdType="pubmed">30528255</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S., Parone P.A., Lopes V.S., Lillo C., McAlonis-Downes M., Lee S.K., Vetto A.P., Petrosyan S., Marsala M., Murphy A.N., et al. Elevated PGC-1&#x3b1; Activity Sustains Mitochondrial Biogenesis and Muscle Function without Extending Survival in a Mouse Model of Inherited ALS. Cell Metab. 2012;15:778&#x2013;786. doi: 10.1016/j.cmet.2012.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.03.019</ArticleId><ArticleId IdType="pmc">PMC3565468</ArticleId><ArticleId IdType="pubmed">22560226</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold A.-S., Gill J., Christe M., Ruiz R., McGuirk S., St-Pierre J., Tabares L., Handschin C. Morphological and functional remodelling of the neuromuscular junction by skeletal muscle PGC-1&#x3b1;. Nat. Commun. 2014;5:3569. doi: 10.1038/ncomms4569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4569</ArticleId><ArticleId IdType="pmc">PMC4846352</ArticleId><ArticleId IdType="pubmed">24686533</ArticleId></ArticleIdList></Reference><Reference><Citation>Willadt S., Nash M., Slater C. Age-related changes in the structure and function of mammalian neuromuscular junctions. Ann. N. Y. Acad. Sci. 2018;1412:41&#x2013;53. doi: 10.1111/nyas.13521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13521</ArticleId><ArticleId IdType="pubmed">29291259</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenheimer J.L. Ultraterminal sprouting in innervated and partially denervated adult and aged rat muscle. Neuroscience. 1990;38:763&#x2013;770. doi: 10.1016/0306-4522(90)90069-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(90)90069-G</ArticleId><ArticleId IdType="pubmed">2270142</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash Y.S., Sieck G.C. Age-related remodeling of neuromuscular junctions on type-identified diaphragm fibers. Muscle Nerve. 1998;21:887&#x2013;895. doi: 10.1002/(SICI)1097-4598(199807)21:7&lt;887::AID-MUS6&gt;3.0.CO;2-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199807)21:7&lt;887::AID-MUS6&gt;3.0.CO;2-2</ArticleId><ArticleId IdType="pubmed">9626248</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T., Maruyama A., Sugiura T., Machida S., Miyata H. Age-related changes in two- and three-dimensional morphology of type-identified endplates in the rat diaphragm. J. Physiol. Sci. JPS. 2009;59:57&#x2013;62. doi: 10.1007/s12576-008-0005-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12576-008-0005-7</ArticleId><ArticleId IdType="pubmed">19340562</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolf R., Khan M.M., Labeit S., Deschenes M.R. Degeneration of Neuromuscular Junction in Age and Dystrophy. Front. Aging Neurosci. 2014;6 doi: 10.3389/fnagi.2014.00099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00099</ArticleId><ArticleId IdType="pmc">PMC4033055</ArticleId><ArticleId IdType="pubmed">24904412</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Lee Y.L., Thompson W.J. Changes in aging mouse neuromuscular junctions are explained by degeneration and regeneration of muscle fiber segments at the synapse. J. Neurosci. 2011;31:14910&#x2013;14919. doi: 10.1523/JNEUROSCI.3590-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3590-11.2011</ArticleId><ArticleId IdType="pmc">PMC3213690</ArticleId><ArticleId IdType="pubmed">22016524</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtney J., Steinbach J.H. Age changes in neuromuscular junction morphology and acetylcholine receptor distribution on rat skeletal muscle fibres. J. Physiol. 1981;320:435&#x2013;447. doi: 10.1113/jphysiol.1981.sp013960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1981.sp013960</ArticleId><ArticleId IdType="pmc">PMC1244058</ArticleId><ArticleId IdType="pubmed">7320945</ArticleId></ArticleIdList></Reference><Reference><Citation>Pestronk A., Drachman D.B., Griffin J.W. Effects of aging on nerve sprouting and regeneration. Exp. Neurol. 1980;70:65&#x2013;82. doi: 10.1016/0014-4886(80)90006-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-4886(80)90006-0</ArticleId><ArticleId IdType="pubmed">7418774</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahim M.A., Robbins N. Ultrastructural studies of young and old mouse neuromuscular junctions. J. Neurocytol. 1982;11:641&#x2013;656. doi: 10.1007/BF01262429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01262429</ArticleId><ArticleId IdType="pubmed">7131048</ArticleId></ArticleIdList></Reference><Reference><Citation>Banker B.Q., Kelly S.S., Robbins N. Neuromuscular transmission and correlative morphology in young and old mice. J. Physiol. 1983;339:355&#x2013;377. doi: 10.1113/jphysiol.1983.sp014721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1983.sp014721</ArticleId><ArticleId IdType="pmc">PMC1199166</ArticleId><ArticleId IdType="pubmed">6310088</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahim M.A., Holley J.A., Robbins N. Scanning and light microscopic study of age changes at a neuromuscular junction in the mouse. J. Neurocytol. 1983;12:13&#x2013;25. doi: 10.1007/BF01148085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01148085</ArticleId><ArticleId IdType="pubmed">6842270</ArticleId></ArticleIdList></Reference><Reference><Citation>Andonian M.H., Fahim M.A. Nerve terminal morphology in C57BL/6NNia mice at different ages. J. Gerontol. 1989;44:B43&#x2013;B51. doi: 10.1093/geronj/44.2.B43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/44.2.B43</ArticleId><ArticleId IdType="pubmed">2921469</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Thompson W.J. Nerve terminal growth remodels neuromuscular synapses in mice following regeneration of the postsynaptic muscle fiber. J. Neurosci. 2011;31:13191&#x2013;13203. doi: 10.1523/JNEUROSCI.2953-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2953-11.2011</ArticleId><ArticleId IdType="pmc">PMC3181159</ArticleId><ArticleId IdType="pubmed">21917802</ArticleId></ArticleIdList></Reference><Reference><Citation>Andonian M.H., Fahim M.A. Effects of endurance exercise on the morphology of mouse neuromuscular junctions during ageing. J. Neurocytol. 1987;16:589&#x2013;599. doi: 10.1007/BF01637652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01637652</ArticleId><ArticleId IdType="pubmed">3694234</ArticleId></ArticleIdList></Reference><Reference><Citation>Wokke J.H., Jennekens F.G., van den Oord C.J., Veldman H., Smit L.M., Leppink G.J. Morphological changes in the human end plate with age. J. Neurol. Sci. 1990;95:291&#x2013;310. doi: 10.1016/0022-510X(90)90076-Y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(90)90076-Y</ArticleId><ArticleId IdType="pubmed">2358822</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha M.C., Pousinha P.A., Correia A.M., Sebasti&#xe3;o A.M., Ribeiro J.A. Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset. PLoS ONE. 2013;8:e73846. doi: 10.1371/journal.pone.0073846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073846</ArticleId><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Tintignac L.A., Brenner H.-R., R&#xfc;egg M.A. Mechanisms Regulating Neuromuscular Junction Development and Function and Causes of Muscle Wasting. Physiol. Rev. 2015;95:809&#x2013;852. doi: 10.1152/physrev.00033.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00033.2014</ArticleId><ArticleId IdType="pubmed">26109340</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomlinson B.E., Irving D., Rebeiz J.J. Total numbers of limb motor neurones in the human lumbosacral cord and an analysis of the accuracy of various sampling procedures. J. Neurol. Sci. 1973;20:313&#x2013;327. doi: 10.1016/0022-510X(73)90193-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(73)90193-7</ArticleId><ArticleId IdType="pubmed">4587145</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M.C., Holland R.L., Hopkins W.G. Motor Nerve Sprouting. Annu. Rev. Neurosci. 1981;4:17&#x2013;42. doi: 10.1146/annurev.ne.04.030181.000313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.ne.04.030181.000313</ArticleId><ArticleId IdType="pubmed">7013635</ArticleId></ArticleIdList></Reference><Reference><Citation>Son Y.J., Trachtenberg J.T., Thompson W.J. Schwann cells induce and guide sprouting and reinnervation of neuromuscular junctions. Trends Neurosci. 1996;19:280&#x2013;285. doi: 10.1016/S0166-2236(96)10032-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-2236(96)10032-1</ArticleId><ArticleId IdType="pubmed">8799973</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolliger M.F., Zurlinden A., Luscher D., Butikofer L., Shakhova O., Francolini M., Kozlov S.V., Cinelli P., Stephan A., Kistler A.D., et al. Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction. J. Cell Sci. 2010 doi: 10.1242/jcs.072090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.072090</ArticleId><ArticleId IdType="pubmed">20980386</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;tikofer L., Zurlinden A., Bolliger M.F., Kunz B., Sonderegger P. Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia. FASEB J. 2011 doi: 10.1096/fj.11-191262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.11-191262</ArticleId><ArticleId IdType="pubmed">21885656</ArticleId></ArticleIdList></Reference><Reference><Citation>Hettwer S., Lin S., Kucsera S., Haubitz M., Oliveri F., Fariello R.G., Ruegg M.A., Vrijbloed J.W. Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction. PLoS ONE. 2014;9:e88739. doi: 10.1371/journal.pone.0088739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0088739</ArticleId><ArticleId IdType="pmc">PMC3919806</ArticleId><ArticleId IdType="pubmed">24520420</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano R., Gilmore K.J., Thompson B.C., Stewart E.M., Waters A.M., Romero-Ortega M., Wallace G.G. Electrical stimulation enhances the acetylcholine receptors available for neuromuscular junction formation. Acta Biomater. 2016 doi: 10.1016/j.actbio.2016.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actbio.2016.08.006</ArticleId><ArticleId IdType="pubmed">27554016</ArticleId></ArticleIdList></Reference><Reference><Citation>Senger J.L., Chan K.M., Macandili H., Chan A.W.M., Verge V.M.K., Jones K.E., Webber C.A. Conditioning electrical stimulation promotes functional nerve regeneration. Exp. Neurol. 2019 doi: 10.1016/j.expneurol.2019.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2019.02.001</ArticleId><ArticleId IdType="pubmed">30731076</ArticleId></ArticleIdList></Reference><Reference><Citation>Potes Y., P&#xe9;rez-Martinez Z., Bermejo-Millo J.C., Rubio-Gonzalez A., Fernandez-Fern&#xe1;ndez M., Bermudez M., Arche J.M., Solano J.J., Boga J.A., Oliv&#xe1;n M., et al. Overweight in the Elderly Induces a Switch in Energy Metabolism that Undermines Muscle Integrity. Aging Dis. 2019;10:217. doi: 10.14336/AD.2018.0430.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2018.0430</ArticleId><ArticleId IdType="pmc">PMC6457058</ArticleId><ArticleId IdType="pubmed">31011474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosole S., Zampieri S., Furlan S., Carraro U., L&#xf6;efler S., Kern H., Volpe P., Nori A. Effects of Electrical Stimulation on Skeletal Muscle of Old Sedentary People. Gerontol. Geriatr. Med. 2018;4:2333721418768998. doi: 10.1177/2333721418768998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2333721418768998</ArticleId><ArticleId IdType="pmc">PMC5896842</ArticleId><ArticleId IdType="pubmed">29662923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern H., Carraro U., Adami N., Biral D., Hofer C., Forstner C., M&#xf6;dlin M., Vogelauer M., Pond A., Boncompagni S., et al. Home-Based Functional Electrical Stimulation Rescues Permanently Denervated Muscles in Paraplegic Patients with Complete Lower Motor Neuron Lesion. Neurorehabilit. Neural Repair. 2010;24:709&#x2013;721. doi: 10.1177/1545968310366129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968310366129</ArticleId><ArticleId IdType="pubmed">20460493</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddocks M., Halliday V., Chauhan A., Taylor V., Nelson A., Sampson C., Byrne A., Griffiths G., Wilcock A. Neuromuscular Electrical Stimulation of the Quadriceps in Patients with Non-Small Cell Lung Cancer Receiving Palliative Chemotherapy: A Randomized Phase II Study. PLoS ONE. 2013;8:e86059. doi: 10.1371/journal.pone.0086059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0086059</ArticleId><ArticleId IdType="pmc">PMC3875585</ArticleId><ArticleId IdType="pubmed">24386491</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Freire M., Adelnia F., Moaddel R., Ferrucci L. Searching for a mitochondrial root to the decline in muscle function with ageing. J. Cachexia Sarcopenia Muscle. 2018;9:435&#x2013;440. doi: 10.1002/jcsm.12313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12313</ArticleId><ArticleId IdType="pmc">PMC5989834</ArticleId><ArticleId IdType="pubmed">29774990</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangarelli A., Chanseaume E., Morio B., Brug&#xe8;re C., Mosoni L., Rousset P., Giraudet C., Patrac V., Gachon P., Boirie Y., et al. Synergistic effects of caloric restriction with maintained protein intake on skeletal muscle performance in 21-month-old rats: A mitochondria-mediated pathway. FASEB J. 2006;20:2439&#x2013;2450. doi: 10.1096/fj.05-4544com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-4544com</ArticleId><ArticleId IdType="pubmed">17142793</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouspillou G., Bourdel-Marchasson I., Rouland R., Calmettes G., Biran M., Deschodt-Arsac V., Miraux S., Thiaudiere E., Pasdois P., Detaille D., et al. Mitochondrial energetics is impaired in vivo in aged skeletal muscle. Aging Cell. 2014;13:39&#x2013;48. doi: 10.1111/acel.12147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12147</ArticleId><ArticleId IdType="pmc">PMC4326861</ArticleId><ArticleId IdType="pubmed">23919652</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouspillou G., Bourdel-Marchasson I., Rouland R., Calmettes G., Franconi J.-M., Deschodt-Arsac V., Diolez P. Alteration of mitochondrial oxidative phosphorylation in aged skeletal muscle involves modification of adenine nucleotide translocator. BBA Bioenerg. 2010;1797:143&#x2013;151. doi: 10.1016/j.bbabio.2009.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2009.09.004</ArticleId><ArticleId IdType="pubmed">19751701</ArticleId></ArticleIdList></Reference><Reference><Citation>Short K.R., Bigelow M.L., Kahl J., Singh R., Coenen-Schimke J., Raghavakaimal S., Nair K.S. Decline in skeletal muscle mitochondrial function with aging in humans. Proc. Natl. Acad. Sci. USA. 2005;102:5618&#x2013;5623. doi: 10.1073/pnas.0501559102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501559102</ArticleId><ArticleId IdType="pmc">PMC556267</ArticleId><ArticleId IdType="pubmed">15800038</ArticleId></ArticleIdList></Reference><Reference><Citation>Drew B., Phaneuf S., Dirks A., Selman C., Gredilla R., Lezza A., Barja G., Leeuwenburgh C. Effects of aging and caloric restriction on mitochondrial energy production in gastrocnemius muscle and heart. Am. J. Physiol. Integr. Comp. Physiol. 2003;284:R474&#x2013;R480. doi: 10.1152/ajpregu.00455.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00455.2002</ArticleId><ArticleId IdType="pubmed">12388443</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Scarabelli C., McCauley R.B., Yuan Z., Di Rezze J., Patel D., Putt J., Raddino R., Allebban Z., Abboud J., Scarabelli G.M., et al. Oral Administration of Amino Acidic Supplements Improves Protein and Energy Profiles in Skeletal Muscle of Aged Rats: Elongation of Functional Performance and Acceleration of Mitochondrial Recovery in Adenosine Triphosphate After Exhaustive Exertion. Am. J. Cardiol. 2008;101:S42&#x2013;S48. doi: 10.1016/j.amjcard.2008.02.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2008.02.080</ArticleId><ArticleId IdType="pubmed">18514626</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansouri A., Muller F.L., Liu Y., Ng R., Faulkner J., Hamilton M., Richardson A., Huang T.-T., Epstein C.J., Van Remmen H. Alterations in mitochondrial function, hydrogen peroxide release and oxidative damage in mouse hind-limb skeletal muscle during aging. Mech. Ageing Dev. 2006;127:298&#x2013;306. doi: 10.1016/j.mad.2005.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2005.11.004</ArticleId><ArticleId IdType="pubmed">16405961</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson M.J., McArdle A. Age-related changes in skeletal muscle reactive oxygen species generation and adaptive responses to reactive oxygen species. J. Physiol. 2011;589:2139&#x2013;2145. doi: 10.1113/jphysiol.2011.206623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2011.206623</ArticleId><ArticleId IdType="pmc">PMC3098693</ArticleId><ArticleId IdType="pubmed">21320885</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman I.M. The Anorexia of Aging. Clin. Geriatr. Med. 2007;23:735&#x2013;756. doi: 10.1016/j.cger.2007.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2007.06.001</ArticleId><ArticleId IdType="pubmed">17923335</ArticleId></ArticleIdList></Reference><Reference><Citation>Thalacker-Mercer A.E., Fleet J.C., Craig B.A., Carnell N.S., Campbell W.W. Inadequate protein intake affects skeletal muscle transcript profiles in older humans. Am. J. Clin. Nutr. 2007;85:1344&#x2013;1352. doi: 10.1093/ajcn/85.5.1344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/85.5.1344</ArticleId><ArticleId IdType="pmc">PMC2447912</ArticleId><ArticleId IdType="pubmed">17490972</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosole S., Carraro U., Kern H., Loefler S., Fruhmann H., Vogelauer M., Burggraf S., Mayr W., Krenn M., Paternostro-Sluga T., et al. Long-Term High-Level Exercise Promotes Muscle Reinnervation with Age. J. Neuropathol. Exp. Neurol. 2014;73:284&#x2013;294. doi: 10.1097/NEN.0000000000000032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000032</ArticleId><ArticleId IdType="pubmed">24607961</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampieri S., Mammucari C., Romanello V., Barberi L., Pietrangelo L., Fusella A., Mosole S., Gherardi G., H&#xf6;fer C., L&#xf6;fler S., et al. Physical exercise in aging human skeletal muscle increases mitochondrial calcium uniporter expression levels and affects mitochondria dynamics. Physiol. Rep. 2016;4:e13005. doi: 10.14814/phy2.13005.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.13005</ArticleId><ArticleId IdType="pmc">PMC5210373</ArticleId><ArticleId IdType="pubmed">28039397</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahim M.A. Endurance exercise modulates neuromuscular junction of C57BL/6NNia aging mice. J. Appl. Physiol. 1997;83:59&#x2013;66. doi: 10.1152/jappl.1997.83.1.59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1997.83.1.59</ArticleId><ArticleId IdType="pubmed">9216945</ArticleId></ArticleIdList></Reference><Reference><Citation>Giudice J., Taylor J.M. Muscle as a paracrine and endocrine organ. Curr. Opin. Pharmacol. 2017;34:49&#x2013;55. doi: 10.1016/j.coph.2017.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2017.05.005</ArticleId><ArticleId IdType="pmc">PMC5808999</ArticleId><ArticleId IdType="pubmed">28605657</ArticleId></ArticleIdList></Reference><Reference><Citation>Handschin C., Kobayashi Y.M., Chin S., Seale P., Campbell K.P., Spiegelman B.M. PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev. 2007;21:770&#x2013;783. doi: 10.1101/gad.1525107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1525107</ArticleId><ArticleId IdType="pmc">PMC1838529</ArticleId><ArticleId IdType="pubmed">17403779</ArticleId></ArticleIdList></Reference><Reference><Citation>Scicchitano B.M., Dobrowolny G., Sica G., Musar&#xf2; A. Molecular Insights into Muscle Homeostasis, Atrophy and Wasting. Curr. Genom. 2018;19:356&#x2013;369. doi: 10.2174/1389202919666180101153911.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389202919666180101153911</ArticleId><ArticleId IdType="pmc">PMC6030854</ArticleId><ArticleId IdType="pubmed">30065611</ArticleId></ArticleIdList></Reference><Reference><Citation>Scicchitano B.M., Rizzuto E., Musar&#xf2; A. Counteracting muscle wasting in aging and neuromuscular diseases: The critical role of IGF-1. Aging. 2009;1:451&#x2013;457. doi: 10.18632/aging.100050.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.100050</ArticleId><ArticleId IdType="pmc">PMC2806025</ArticleId><ArticleId IdType="pubmed">20157530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., Goldberg A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004;117:399&#x2013;412. doi: 10.1016/S0092-8674(04)00400-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(04)00400-3</ArticleId><ArticleId IdType="pmc">PMC3619734</ArticleId><ArticleId IdType="pubmed">15109499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascenzi F., Barberi L., Dobrowolny G., Villa Nova Bacurau A., Nicoletti C., Rizzuto E., Rosenthal N., Scicchitano B.M., Musar&#xf2; A. Effects of IGF-1 isoforms on muscle growth and sarcopenia. Aging Cell. 2019;18:e12954. doi: 10.1111/acel.12954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12954</ArticleId><ArticleId IdType="pmc">PMC6516183</ArticleId><ArticleId IdType="pubmed">30953403</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheb-Al-Zamani M., Yan Y., Farber S.J., Hunter D.A., Newton P., Wood M.D., Stewart S.A., Johnson P.J., Mackinnon S.E. Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence. Exp. Neurol. 2013;247:165&#x2013;177. doi: 10.1016/j.expneurol.2013.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.04.011</ArticleId><ArticleId IdType="pmc">PMC3863361</ArticleId><ArticleId IdType="pubmed">23644284</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>